Information Provided By: 
Fly News Breaks for March 6, 2018
MGLN
Mar 6, 2018 | 05:53 EDT
Jefferies analyst David Styblo expects shares of Magellan Health to react positively today following the Arizona Medicaid contract results. Magellan is the only non-incumbent managed care organization to win a share of the $4.5B reprocurement, Styblo tells investors in a research note. He notes that all six incumbents were also awarded contracts. He sees the win as a positive for Magellan Health and keeps a Buy rating on the shares with a $120 price target.
News For MGLN From the Last 2 Days
There are no results for your query MGLN
